Shira Medtech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.31 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -68.37%
- Profit Growth -322.47%
- Ebitda 21.96%
- Net Worth -1244.10%
- Total Assets 216.15%
About Shira Medtech
Shira Medtech Private Limited (SMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 July 2016 (Eight years and six months 15 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.31 M, as per Ministry of Corporate Affairs (MCA) records.
Sahaj Parikh, Shivna Majmudar, and Anand Parikh serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33125GJ2016PTC093007
-
Company No.
093007
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jul 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shira Medtech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Parikh
|
Director | 19-Jul-2016 | Current |
|
Sahaj Parikh
|
Director | 19-Jul-2016 | Current |
|
Shivna Majmudar
|
Additional Director | 15-Apr-2024 | Current |
Financial Performance of Shira Medtech.
Shira Medtech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.37% decrease. The company also saw a substantial fall in profitability, with a 322.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1244.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shira Medtech?
In 2022, Shira Medtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Adani Vizag Coal Terminal Private LimitedShivna Majmudar is a mutual person
-
Adani Harbour Services Limited
Shivna Majmudar is a mutual person
-
Sa Innovations Private LimitedSahaj Parikh and Anand Parikh are mutual person
-
Dishman Infrastructure Limited
Shivna Majmudar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shira Medtech?
Unlock and access historical data on people associated with Shira Medtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shira Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shira Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
